Alyeska Investment Group »

Monopar Therapeutics shares owned by Alyeska Investment Group

Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by Alyeska Investment Group from 13F filings

Historical chart of Alyeska Investment Group investment in Monopar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monopar Therapeutics held by Alyeska Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monopar Therapeutics by Alyeska Investment Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.6M 40k 65.30
2025-09-30 $998k 12k 81.67

More positions owned by Alyeska Investment Group

Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Boeing Company (BA)
Take-Two Interactive Software (TTWO)
Doordash Cl A (DASH)
Burlington Stores (BURL)
Equinix (EQIX)
Danaher Corporation (DHR)
Broadcom (AVGO)
Meta Platforms Cl A (META)
At&t (T)
Coreweave Com Cl A (CRWV)
Kroger (KR)
McDonald's Corporation (MCD)

View all positions for Alyeska Investment Group

Top funds holding Monopar Therapeutics

Henderson Group
Adage Capital Partners GP
RA Capital Management
Saturn V Capital Management
Vanguard Group
BlackRock
ADAR1 Capital Management
Wellington Management Company
Siren
Deerfield Management Company
TCG Crossover Management
Polar Capital Holdings
Geode Capital Management
Deep Track Capital
Vivo Capital

View all funds holding Monopar Therapeutics